Literature DB >> 33441741

A method to alleviate false-positive results of the Elecsys HIV combi PT assay.

Xiaolan Lu1,2,3, Minghong Zhang4, Wen Liu1,2,3, Nan Sheng4, Qin Du1,2,3, Maoxin Zhang1, Xiaolan Guo1,2,3, Guangrong Wang5,6,7, Qiang Wang8,9,10.   

Abstract

To explore the effects of urea dissociation on reducing false-positive results of  the Elecsys HIV combi PT assay. A retrospective analysis was used to evaluate the false-positive rate of the Elecsys HIV combi PT assay. Six false-positive sera, six positive sera and six sera from patients with early HIV infection were collected. Dissociation was performed using 1 mol/L, 2 mol/L, 4 mol/L, 6 mol/L, or 8 mol/L urea, and HIV screening assay were then detected to select the appropriate concentration of urea dissociation. Next, 55 false-positive sera and 15 sera from early HIV infection were used to verify the best concentration of urea to achieve dissociation. Retrospective analysis showed that the COI of the Elecsys HIV combi PT assay in false-positive sera ranged from 1.0 to 200.0, and approximately 97.01%(227/234) of false-positive sera were in the range of 1.0-15.0. The avidity index (AI) in positive and false-positive sera decreased as the urea dissociation concentration increased. When the dissociation concentration was 6 mol/L, the AI of false-positive serum was between 0.0234 and 0.2567, and the AI of early HIV infection sera was between 0.4325 and 0.5017. The difference in AI between false-positive and positive samples was significant. When negativity was defined as an AI of less than 0.3970, the sensitivity and specificity were 100.0% and 100.0%, respectively. Urea-mediated dissociation could significantly reduce the false-positive rate of the Elecsys HIV combi PT assay with a low COI. Our findings provided a reference for distinguishing positive and false-positive of the Elecsys HIV combi PT assay.

Entities:  

Year:  2021        PMID: 33441741      PMCID: PMC7807026          DOI: 10.1038/s41598-020-80047-0

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  26 in total

1.  Comparison of Detection Limits of Fourth- and Fifth-Generation Combination HIV Antigen-Antibody, p24 Antigen, and Viral Load Assays on Diverse HIV Isolates.

Authors:  Mars Stone; John Bainbridge; Ana M Sanchez; Sheila M Keating; Andrea Pappas; Wes Rountree; Chris Todd; Sonia Bakkour; Mark Manak; Sheila A Peel; Robert W Coombs; Eric M Ramos; M Kathleen Shriver; Paul Contestable; Sangeetha Vijaysri Nair; David H Wilson; Martin Stengelin; Gary Murphy; Indira Hewlett; Thomas N Denny; Michael P Busch
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

2.  Sensitivity of the STAT-VIEW rapid self-test and implications for use during acute HIV infection.

Authors:  Narjis Boukli; Anders Boyd; Noémie Wendremaire; Pierre-Marie Girard; Julie Bottero; Laurence Morand-Joubert
Journal:  Sex Transm Infect       Date:  2017-08-23       Impact factor: 3.519

3.  Clinical and epidemiologic features of primary HIV infection.

Authors:  T Schacker; A C Collier; J Hughes; T Shea; L Corey
Journal:  Ann Intern Med       Date:  1996-08-15       Impact factor: 25.391

4.  BioRad BioPlex® HIV Ag-Ab assay: Incidence of false positivity in a low-prevalence population and its effects on the current HIV testing algorithm.

Authors:  Jayme Parker; Ana Fiorella Carrasco; Jack Chen
Journal:  J Clin Virol       Date:  2019-04-06       Impact factor: 3.168

5.  Antiretroviral treatment monitoring with an improved HIV-1 p24 antigen test: an inexpensive alternative to tests for viral RNA.

Authors:  J Schüpbach; J Böni; M Flepp; Z Tomasik; H Joller; M Opravil
Journal:  J Med Virol       Date:  2001-10       Impact factor: 2.327

6.  [Survival and disease progression in 251 patients with HIV-1 infection. Study of p24 antigen and viral burden as prognosis makers. Their value at 4 years of follow-up].

Authors:  M Rubio Caballero; C Rubio Rivas; A Nogués Biau; M Falguera Sacrest; A Manonelles Fernández
Journal:  An Med Interna       Date:  2001-10

7.  [Features and influencing factors of self-discrimination among HIV/AIDS patients according to sex].

Authors:  L H Ju; P Lyu; P Xu; W Y Chen; H J He; L P Ma
Journal:  Zhonghua Yu Fang Yi Xue Za Zhi       Date:  2016-10-06

8.  The characteristics of screening and confirmatory test results for HIV in Xi'an, China.

Authors:  Linchuan Wang; Kai-Hua Zhou; He-Ping Zhao; Ji-Han Wang; Hai-Chao Zheng; Yan Yu; Wei Chen
Journal:  PLoS One       Date:  2017-07-07       Impact factor: 3.240

9.  Lamivudine Concentration in Hair and Prediction of Virologic Failure and Drug Resistance among HIV Patients Receiving Free ART in China.

Authors:  Jing Yan; Jia Liu; Bin Su; Xiaohong Pan; Zhe Wang; Jianjun Wu; Jiafeng Zhang; Yuhua Ruan; Jenny Hsi; Lingjie Liao; Yiming Shao; Hui Xing
Journal:  PLoS One       Date:  2016-04-27       Impact factor: 3.240

10.  Altered Memory Circulating T Follicular Helper-B Cell Interaction in Early Acute HIV Infection.

Authors:  Roshell Muir; Talibah Metcalf; Virginie Tardif; Hiroshi Takata; Nittaya Phanuphak; Eugene Kroon; Donn J Colby; Rapee Trichavaroj; Victor Valcour; Merlin L Robb; Nelson L Michael; Jintanat Ananworanich; Lydie Trautmann; Elias K Haddad
Journal:  PLoS Pathog       Date:  2016-07-27       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.